2012 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 1.947.546 | 230.979 | 1 | ||
2012 | 0 | 3.861.450 | 211.850 | 1 |
Total number of partners: 16
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 16
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-03-01 | Adenovirus Vector Technology: Next Generation Systems for Medical Therapy | AD-VEC | participant | 1.947.546 | 5 |
2012-04-01 | ADenoViruses as novel clinical treatments | ADVance | participant | 3.861.450 | 13 |